ChartMill assigns a fundamental rating of 5 / 10 to GHDX.
ChartMill assigns a valuation rating of 0 / 10 to GENOMIC HEALTH INC (GHDX). This can be considered as Overvalued.
GENOMIC HEALTH INC (GHDX) has a profitability rating of 6 / 10.
The Price/Earnings (PE) ratio for GENOMIC HEALTH INC (GHDX) is 44.36 and the Price/Book (PB) ratio is 6.83.
The Earnings per Share (EPS) of GENOMIC HEALTH INC (GHDX) is expected to grow by 50.48% in the next year.